RxDoctor Payments Data

Edan Gilat, MD

Psychiatry · Worthington, OHNPI 1497046841

Payments from drug & device makers

$6,416in general payments, 2019–2025

Across 452 payments — averaging $14.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Lundbeck LLC$665
  • Vanda Pharmaceuticals Inc.$492
  • Otsuka America Pharmaceutical, Inc.$487
  • Supernus Pharmaceuticals, Inc.$475
  • Takeda Pharmaceuticals U.S.A., Inc.$395
  • plus $2K from 23 others

What the payments were for

  • Food & beverage$6,37999%
  • Education$371%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,416 in reported general payments places this provider in the 85th percentile of 1,119 psychiatry providers in Ohio.

See all psychiatry providers in Ohio

Medicare billing

Part B allowed, 2024
$34,611
Medicare patients
80
Services billed
416

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate52$421,584
VraylarCariprazine Hcl53$75,470
VyvanseLisdexamfetamine Dimesylate38$17,652
TrintellixVortioxetine Hydrobromide25$12,916
Quetiapine Fumarate ErQuetiapine Fumarate42$9,728
Effexor XrVenlafaxine Hcl12$7,423
Lurasidone Hcl27$6,645
Vilazodone Hcl72$5,450
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine146$5,422
Aripiprazole94$4,104
Clozapine73$3,813
Bupropion XlBupropion Hcl95$3,764
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine51$3,460
Duloxetine Hcl130$3,260
Dextroamphetamine Sulfate ErDextroamphetamine Sulfate23$3,068

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$262$421,58452 claims
AbbVieVraylar$1,495$75,47053 claims
Takeda Pharmaceuticals U.S.A., Inc.Vyvanse, Trintellix$395$30,56863 claims
Almatica Pharma LLCSertraline Hcl$137$805127 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,119 psychiatry providers in Ohio.

Other psychiatry in Worthington

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →